Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 8.3x - 9.1x | 8.7x |
| Selected Fwd Ps Multiple | 7.4x - 8.2x | 7.8x |
| Fair Value | ¥6.98 - ¥7.71 | ¥7.35 |
| Upside | -46.8% - -41.2% | -44.0% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Peijia Medical Limited | 999,600.0% | SEHK:9996 |
| Beijing Bohui Innovation Biotechnology Group Co., Ltd. | 30,031,800.0% | SZSE:300318 |
| MicroTech Medical (Hangzhou) Co., Ltd. | 223,500.0% | SEHK:2235 |
| Maider Medical Industry Equipment Co. Ltd. | 68,831,000.0% | SHSE:688310 |
| Shanghai INT Medical Instruments Co., Ltd. | 150,100.0% | SEHK:1501 |
| QITIAN Technology Group Co., Ltd. | 30,006,100.0% | SZSE:300061 |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| 9996 | 300318 | 2235 | 688310 | 1501 | 300061 | |||
| SEHK:9996 | SZSE:300318 | SEHK:2235 | SHSE:688310 | SEHK:1501 | SZSE:300061 | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | 101.1% | 6.3% | 46.1% | 5.6% | 24.4% | -12.7% | ||
| 3Y CAGR | 65.2% | 6.0% | 31.7% | -4.5% | 22.4% | -15.9% | ||
| Latest Twelve Months | 39.5% | -25.0% | 36.5% | -50.0% | 13.2% | -42.2% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -1542.0% | -16.2% | -40.1% | 16.6% | 26.7% | -31.3% | ||
| Prior Fiscal Year | -89.0% | -2.4% | -49.4% | 20.8% | 20.2% | -50.8% | ||
| Latest Fiscal Year | -36.8% | 1.1% | -18.3% | -7.3% | 21.2% | -34.2% | ||
| Latest Twelve Months | -36.8% | -1.9% | -18.3% | -17.1% | 21.2% | -37.4% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | -21.9x | 65.6x | -6.5x | -113.2x | 10.2x | -859.8x | ||
| Price / LTM Sales | 7.5x | 6.4x | 7.4x | 12.1x | 4.0x | 15.7x | ||
| LTM P/E Ratio | -20.4x | -343.5x | -40.3x | -70.6x | 18.8x | -41.9x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 4.0x | 7.4x | 12.1x | |||||
| Historical LTM P/S Ratio | 2.4x | 3.7x | 10.7x | |||||
| Selected Price / Sales Multiple | 8.3x | 8.7x | 9.1x | |||||
| (x) LTM Sales | 550 | 550 | 550 | |||||
| (=) Equity Value | 4,551 | 4,790 | 5,030 | |||||
| (/) Shares Outstanding | 659.0 | 659.0 | 659.0 | |||||
| Implied Value Range | 6.91 | 7.27 | 7.63 | |||||
| FX Rate: CNY/CNY | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 6.91 | 7.27 | 7.63 | 13.12 | ||||
| Upside / (Downside) | -47.4% | -44.6% | -41.8% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 9996 | 300318 | 2235 | 688310 | 1501 | 300061 | |
| Value of Common Equity | 4,647 | 5,008 | 2,639 | 2,937 | 3,618 | 8,646 | |
| (/) Shares Outstanding | 665.7 | 816.9 | 418.6 | 163.6 | 176.0 | 659.0 | |
| Implied Stock Price | 6.98 | 6.13 | 6.30 | 17.95 | 20.56 | 13.12 | |
| FX Conversion Rate to Trading Currency | 0.91 | 1.00 | 0.91 | 1.00 | 0.91 | 1.00 | |
| Implied Stock Price (Trading Cur) | 7.64 | 6.13 | 6.90 | 17.95 | 22.50 | 13.12 | |
| Trading Currency | HKD | CNY | HKD | CNY | HKD | CNY | |
| FX Rate to Reporting Currency | 0.91 | 1.00 | 0.91 | 1.00 | 0.91 | 1.00 | |